While certain types of human papillomavirus (HPV) cause cervical cancer, other types can cause genital warts. HPV doesn't discriminate. According to the Centers for Disease Control and Prevention, there are about 1 million new cases of genital warts each year in the United States.* There is no one "type" of person who gets genital warts. So they are something we should all be aware of.
Unlike cervical cancer, genital warts are not life threatening. But, they can be life altering. Even after treatment, genital warts can come back. In fact, 25% of cases come back within 3 months.
*Both men and women.
GARDASIL is the only cervical cancer vaccine that helps protect against 4 types of human papillomavirus (HPV): 2 types that cause 70% of cervical cancer cases, and 2 more types that cause 90% of genital warts cases. GARDASIL is for girls and young women ages 9 to 26.
Anyone who is allergic to the ingredients of GARDASIL should not receive the vaccine. GARDASIL is not for women who are pregnant. GARDASIL does not treat cervical cancer or genital warts.
GARDASIL may not fully protect everyone, and does not prevent all types of cervical cancer, so it’s important to continue routine cervical cancer screenings. GARDASIL will not protect against diseases caused by other HPV types or against diseases not caused by HPV.
The side effects include pain, swelling, itching, and redness at the injection site, fever, nausea, dizziness, vomiting, and fainting. GARDASIL is given as 3 injections over 6 months.
Only a doctor or healthcare professional can decide if GARDASIL is right for you or your daughter.
Read the Patient Product Information or the Prescribing Information for GARDASIL.
This site is intended only for residents of the United States, its territories, and Puerto Rico.
GARDASIL is a registered trademark of Merck & Co., Inc.
20802636(2)-03/08-GRD
This site is intended only for residents of the United States, its territories, and Puerto Rico.
GARDASIL is a registered trademark of Merck & Co., Inc.
20802636(2)-03/08-GRD